Legal Representation
Attorney
Laura J. Winston
USPTO Deadlines
Application History
48 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 29, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 29, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 4, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 3, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Dec 8, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 2, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 8, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 6, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Dec 6, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 6, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 6, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 6, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 6, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 24, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 22, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 22, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 22, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 22, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 22, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 22, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 22, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 22, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 22, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 24, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 22, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 22, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 22, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 22, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 27, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 27, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 7, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 23, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 23, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 23, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 14, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 31, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 6, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes; chemical preparations for medical purposes, namely, for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparation for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparation for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium
Class 010
Medical apparatus and instruments, namely, device for the delivery of medical gas to be used at home or in a hospital; Diagnostic, examination, and monitoring equipment, namely, medical and medicine diagnostic systems, detection systems, and monitoring systems for chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium and delivery systems of nitric oxide for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems; apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients
Class 042
Scientific research for medical purposes in the area of respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for respiratory diseases
Classification
International Classes
005
010
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CANCER"